Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins

Journal of Neurochemistry

Volumn 86, Issue 2, 2003, Pages 363-373

  Hyun, Dong Hoon ^a   Lee, MoonHee ^a   Halliwell, Barry ^b   Jenner, Peter ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Aggregates; Amyotrophic lateral sclerosis; Lactacystin; Proteasomal inhibition; Protein nitration; SOD 1

Indexed keywords

ALPHA TUBULIN; LACTACYSTIN; N(G) NITROARGININE METHYL ESTER; PARKIN; SUPEROXIDE DISMUTASE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL LOSS; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MUTATION; NITRATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; WILD TYPE;

ACETYLCYSTEINE; ALPHA-SYNUCLEIN; CELL LINE; CELL SURVIVAL; CYSTEINE ENDOPEPTIDASES; ENZYME INHIBITORS; GENE TRANSFER TECHNIQUES; HUMANS; LIGASES; MACROMOLECULAR SUBSTANCES; MULTIENZYME COMPLEXES; NERVE TISSUE PROTEINS; NEUROFILAMENT PROTEINS; NITRATES; NITRIC OXIDE SYNTHASE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; SUPEROXIDE DISMUTASE; SYNUCLEINS; TUBULIN; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 0038155130     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01841.x     Document Type: Article

References (43)

1. Alves-Rodrigues A., Gregori L. and Figueiredo-Pereira M. E. (1998) Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci. 21, 516-520.
2. Angulo A., Suto C., Boehm M. F., Heyman R. A. and Ghazal P. (1995) Retinoid activation of retinoic acid receptors but not of retinoid X receptors promotes cellular differentiation and replication of human cytomegalovirus in embryonal cells. J. Virol. 69, 3831-3837.
3. Bence N. F., Sampat R. M. and Kopito R. R. (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 1552-1555.
4. Biedler J. L., Roffler-Tarlov S., Schachner M. and Freedman L. S. (1978) Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38, 3751-3757.
5. Brown R. H. Jr (1995) Amyotrophic lateral sclerosis: recent insight from genetics and transgenic mice. Cell 80, 687-692.
6. Bruijn L. I., Beal M. F., Becher M. W., Schulz J. B., Wong P. C., Price D. L. and Cleveland D. W. (1997) Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc. Natl Acad. Sci. USA 94, 7606-7611.
7. Bruijn L. I., Houseweart M. K., Kato S., Anderson K. L., Anderson S. D., Ohama E., Reaume A. G., Scott R. W. and Cleveland D. W. (1998) Aggregation and motor neuron toxicity of an ALS-linked SOD-1 mutant independent from wild-type SOD-1. Science 281, 1851-1854.
8. Canu N., Barbato C., Ciotti M. T., Serafino A., Dus L. and Calissano P. (2000) Proteasome involvement and accumulation of ubiquitinated proteins in cerebellar granule neurons undergoing apoptosis. J. Neurosci. 20, 589-599.
9. Chou S. M., Taniguchi A., Wang H. S. and Festoff B. W. (1998) Serpinserine protease-like complexes within neurofilament conglomerates of motoneurons in amyotrophic lateral sclerosis. J. Neurol. Sci. 160, S73-S79.
10. Ciechanover A., Orian A. and Schwartz A. L. (2000) The ubiquitin-mediated proteolytic pathway: mode of action and clinical implications. J. Cell Biochem. Suppl. 34, 40-51.
11. Crow J. P. YeY. Z., Strong M., Kirk M., Barnes S. and Beckman J. S. (1997a) Superoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament-L. J. Neurochem. 69, 1945-1953.
12. Crow J. P., Sampson J. B., Zhuang Y., Thompson J. A. and Beckman J. S. (1997b) Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to catalysis of tyrosine nitration by peroxynitrite. J. Neurochem. 69, 1936-1944.
13. Eiserich J. P., Estevez A. G., Bamberg T. V., Ye Y. Z., Chumley P. H., Beckman J. S. and Freeman B. A. (1999) Microtubule dysfunction by posttranslational nitrotyrosination of α-tubulin: a nitric oxide-dependent mechanism of cellular injury. Proc. Natl Acad. Sci. USA 96, 6365-6370.
14. Fenteany G. and Schreiber S. L. (1998) Lactacystin, proteasome function, and cell fate. J. Biol. Chem. 273, 8545-8548.
15. Gai W. P., Power J. H. T., Blumbergs P. C., Culvenor J. G. and Jensen P. H. (1999) α-Synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components. J. Neurochem. 73, 2093-2100.
16. Giasson B. I., Duda J. E., Murray I. V., Chen Q., Souza J. M., Hurtig H. I., Ischiropoulos H., Trojanowski J. Q. and Lee V. M. (2000) Oxidative damage linked to neurodegeneration by selective alphasynuclein nitration in synucleinopathy lesions. Science 290, 985-989.
17. Greenacre S. A. and Ischiropoulos H. (2001) Biological tyrosine nitration: a pathological function of nitric oxide and reactive oxygen species. Free Rad. Res. 34, 541-581.
18. Guevara I., Iwanejko J., Dembińska-Kieć A., Pankiewicz J., Wanat A., Anna P, Goła̧bek I., Bartuś S., Malczewska-Malec M. and Szczudlik A. (1998) Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin. Chim. Acta 274, 177-188.
19. Halliwell B. (2002) Hypothesis: proteasomal dysfunction a primary event in neurogeneration that leads to nitrative and oxidative stress and subsequent cell death. Ann. NY Acad. Sci. 962, 182-194.
20. Halliwell B. and Jenner P. (1998) Impaired clearance of oxidised proteins in neurodegenerative diseases. Lancet 351, 1510.
21. Halliwell B., Zhao K. and Whiteman M. (1999) Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: a personal view of recent controversies. Free Radic. Res. 31, 651-669.
22. Hoffman E. K., Wilcox H. M., Scott R. W. and Siman R. (1996) Proteasome inhibition enhances the stability of mouse Cu/Zn superoxide dismutase with mutations linked to familial amyotrophic lateral sclerosis. J. Neurol. Sci. 139, 15-20.
23. Hyun D.-H., Lee M., Halliwell B. and Jenner P. (2002) Proteasomal dysfunction induced by 4-hydroxy-2,3-trans-nonenal, an end-product of lipid peroxidation: a mechanism contributing to neurodegeneration? J. Neurochem. 83, 360-370.
24. Johnson W. G. (2000) Late-onset neurodegenerative diseases-the role of protein insolubility. J. Anat. 196, 609-616.
25. Johnston J. A., Dalton M. J., Gurney M. E. and Kopito R. R. (2000) Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 97, 12571-12576.
26. Keller J. N., Hanni K. B. and Markesbery W. R. (2000) Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75, 436-439.
27. Kelner G. S., Lee M., Clark M. E., Maciejewski D., McGrath D., Rabizadeh S., Lyons T., Bredesen D., Jenner P. and Maki R. A. (2000) The copper transport protein Atox1 promotes neuronal survival. J. Biol. Chem. 275, 580-584.
28. Kostic V., Jackson-Lewis V., de Bilbao F., Dubois-Dauphin M. and Przedborski S. (1997) Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277, 559-562.
29. Lee M., Hyun D.-H., Jenner P. and Halliwell B. (2001a) Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative damage and antioxidant defences: relevance to Down's syndrome and familial amyotrophic lateral sclerosis. J. Neurochem. 76, 957-965.
30. Lee M. H., Hyun D.-H., Jenner P. and Halliwell B. (2001b) Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production. J. Neurochem. 78, 32-41.
31. McNaught K. S., Belizaire R., Jenner P., Olanow C. W. and Isacson O. (2002) Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease. Neurosci. Lett. 326, 155-158.
32. McNaught K. S., Olanow C. W., Halliwell B., Isacson O. and Jenner P. (2001) Failure of the ubiquitin-proteasome system in Parkinson's disease. Nat. Rev. Neurosci. 2, 589-594.
33. Mezey E., Dehejia A., Harta G., Papp M. I., Polymeropoulos M. H. and Brownstein M. J. (1998) α-Synuclein in neurodegenerative disorders, murderer or accomplice? Nat. Med. 4, 755-759.
34. 1B-adrenergic receptor induces a synucleinopathy with excessive tyrosine nitration but decreased phosphorylation. J. Neurochem. 83, 623-634.
35. Paxinou E., Chen Q., Weisse M., Giasson B. I., Norris E. H., Rueter S. M., Trojanowski J. Q., Lee V. M. and Ischiropoulos H. (2001) Induction of alpha-synuclein aggregation by intracellular nitrative insult. J. Neurosci. 21, 8053-8061.
36. Pedersen W. A., Fu W., Keller J. N., Markesbery W. R., Appel S., Smith R. G., Kasarskis E. and Mattson M. P. (1998) Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann. Neurol. 44, 819-824.
37. Przedborski S., Chen Q., Vila M., Giasson B. I., Djaldatti R., Vukosavic S., Souza J. M., Jackson-Lewis V. V., Lee V. M. and Ischiropoulos H. (2001) Oxidative post-translational modifications of α-synuclein in the 1-methyl-4-phenyl-I,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. J. Neurochem. 76, 637-640.
38. Rideout H. J., Larsen K. E., Sulzer D. and Stefanis L. (2001) Proteasomal inhibition leads to formation of ubiquitin/alpha-synucleinimmuno-reactive inclusions in PC12 cells. J. Neurochem. 78, 899-908.
39. Rosen R. R., Siddique T., Patterson D., Figlewicz D. E., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J. P., Deng H. X., Ramani Z., Krizus A., McKenna-Yasek D., Cayabiyab A., Gaston S. M., Beger R., Tanzi R. E., Halperin J. J., Herzfeldt B., Berg R., Hung W. Y., Bird T., Deng G., Mulder D. W., Smyth C., Laing N. G., Soriano E., Pericak-Vance M. A., Haines J., Rouleau G. A., Gusella J. S., Horvitz H. R. and Brown R. H. (1993) Mutations in Cu/Zn superoxide dimutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62.
40. Shibata N., Nagai R., Miyata S., Jono T., Horiuchi S., Hirano A., Kato S., Sasaki S., Asayama K. and Kobayashi M. (2000) Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Acta Neuropathol. 100, 275-284.
41. Shimura H., Hattori N., Kubo S., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K. and Suzuki T. (2000) Familial Parkinson disease gene product, parkin, is a ubiquitinprotein ligase. Nat. Genet. 25, 302-305.
42. Takahashi T., Yamashita H., Nakamura T., Nagano Y. and Nakamura S. (2002) Tyrosine 125 of α-synuclein plays a critical role for dimerization following nitrative stress. Brain Res. 938, 73-80.
43. Voges D., Zwickl P. and Baumeister W. (1999) The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68, 1015-1068.